This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Deverra Therapeutics Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Mary Prieve: Innovator in Immunotherapy
Introduction
Mary Prieve is a notable inventor based in Seattle, WA (US). She has made significant contributions to the field of immunotherapy, particularly through her innovative research and development efforts.
Latest Patents
Mary Prieve holds a patent for "NK Cell Compositions and Preparations for Immunotherapy and Methods for Their Production." This patent highlights her work in creating effective treatments that harness the power of natural killer cells to combat diseases.
Career Highlights
Mary is currently associated with Deverra Therapeutics Inc., where she continues to advance her research in immunotherapy. Her dedication to innovation has positioned her as a key figure in her field.
Collaborations
Throughout her career, Mary has collaborated with esteemed colleagues, including Colleen Delaney and Carrie Stoltzman. These partnerships have further enriched her work and contributed to the success of her projects.
Conclusion
Mary Prieve's contributions to immunotherapy through her patent and collaborative efforts underscore her importance as an inventor in the medical field. Her work continues to inspire advancements in treatment methodologies.